Allogeneic cell therapy fares well in phase III osteoarthritis trial

AMSTERDAM – A novel intra-articular allogeneic cell therapy improved knee osteoarthritis pain, physical activity, and patients’ quality of life in a randomized, placebo-controlled, double-blind,...
Source: Rheumatology News - Category: Rheumatology Source Type: research